What is the address of DR. E. OBRIE - DR. H. VAN HOOREBEKE?

The registered office of DR. E. OBRIE - DR. H. VAN HOOREBEKE is located at Gravin Mad. d'Alcantaralaan 67, 9971 Kaprijke.

Is DR. E. OBRIE - DR. H. VAN HOOREBEKE still active?

Yes. According to the CBE (16 September 2026) DR. E. OBRIE - DR. H. VAN HOOREBEKE is active, legal situation “Normale toestand”, started on 5 July 2000.

Is DR. E. OBRIE - DR. H. VAN HOOREBEKE registered on Peppol?

No, DR. E. OBRIE - DR. H. VAN HOOREBEKE is currently not registered on the Peppol network.

What is the enterprise number of DR. E. OBRIE - DR. H. VAN HOOREBEKE?

The enterprise number of DR. E. OBRIE - DR. H. VAN HOOREBEKE is BE0472308440.

When was DR. E. OBRIE - DR. H. VAN HOOREBEKE founded?

DR. E. OBRIE - DR. H. VAN HOOREBEKE was founded on 5 July 2000.

Who are the directors of DR. E. OBRIE - DR. H. VAN HOOREBEKE?

According to the 2025 annual accounts, the directors of DR. E. OBRIE - DR. H. VAN HOOREBEKE are: Eric Obrie, Hilde Van Hoorebeke.

Is DR. E. OBRIE - DR. H. VAN HOOREBEKE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 July 2000; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. E. OBRIE - DR. H. VAN HOOREBEKE make in 2025?

DR. E. OBRIE - DR. H. VAN HOOREBEKE posted a profit after taxes of € 99,357 in financial year 2025.

What is the revenue of DR. E. OBRIE - DR. H. VAN HOOREBEKE?

As a small company, DR. E. OBRIE - DR. H. VAN HOOREBEKE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 143,945.

DR. E. OBRIE - DR. H. VAN HOOREBEKE (Private Limited)

Dossier DR. E. OBRIE - DR. H. VAN HOOREBEKE, printed on 16 September 2026 from databakkes.be/en/0472308440/dr-e-obrie-dr-h-van-hoorebeke. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. E. OBRIE - DR. H. VAN HOOREBEKE from Kaprijke, company number BE0472308440, closed financial year 2025 with a result of € 99,357 after tax. For that financial year DR. E. OBRIE - DR. H. VAN HOOREBEKE recorded a gross margin of € 143,945 and equity of € 351,201. Compared with financial year 2024, the result moved from € 88,145 to € 99,357. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 351,201

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 99,357

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 137,725

▼ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 70,500 paid out

71 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 1,455

▲ 228% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 16,832

▲ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 27,953

▲ 5% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 51,533 Gross margin 2022: € 51,533 First fiscal year in the series	€ 65,661 Gross margin 2023: € 65,661 ▲ 27% vs 2022 (€ 51,533) Favourable step	€ 131,473 Gross margin 2024: € 131,473 ▲ 100% vs 2023 (€ 65,661) Favourable step	€ 143,945 Gross margin 2025: € 143,945 ▲ 9% vs 2024 (€ 131,473) Favourable step	▲ 9%
Profit after taxes	€ 41,591 Profit after taxes 2022: € 41,591 First fiscal year in the series	€ 43,243 Profit after taxes 2023: € 43,243 ▲ 4% vs 2022 (€ 41,591) Favourable step	€ 88,145 Profit after taxes 2024: € 88,145 ▲ 104% vs 2023 (€ 43,243) Favourable step	€ 99,357 Profit after taxes 2025: € 99,357 ▲ 13% vs 2024 (€ 88,145) Favourable step	▲ 13%
Equity	€ 192,556 Equity 2022: € 192,556 First fiscal year in the series	€ 234,199 Equity 2023: € 234,199 ▲ 22% vs 2022 (€ 192,556) Favourable step	€ 322,343 Equity 2024: € 322,343 ▲ 38% vs 2023 (€ 234,199) Favourable step	€ 351,201 Equity 2025: € 351,201 ▲ 9% vs 2024 (€ 322,343) Favourable step	▲ 9%
Total debts	€ 43,190 Total debts 2022: € 43,190 First fiscal year in the series	€ 51,208 Total debts 2023: € 51,208 ▲ 19% vs 2022 (€ 43,190) Unfavourable step	€ 66,734 Total debts 2024: € 66,734 ▲ 30% vs 2023 (€ 51,208) Unfavourable step	€ 62,117 Total debts 2025: € 62,117 ▼ 7% vs 2024 (€ 66,734) Favourable step	▼ 7%
Cash	€ 61,715 Cash 2022: € 61,715 First fiscal year in the series	€ 101,847 Cash 2023: € 101,847 ▲ 65% vs 2022 (€ 61,715) Favourable step	€ 172,638 Cash 2024: € 172,638 ▲ 70% vs 2023 (€ 101,847) Favourable step	€ 137,725 Cash 2025: € 137,725 ▼ 20% vs 2024 (€ 172,638) Unfavourable step	▼ 20%
Retained profit	€ 173,956 Retained profit 2022: € 173,956 First fiscal year in the series	€ 215,599 Retained profit 2023: € 215,599 ▲ 24% vs 2022 (€ 173,956) Favourable step	€ 303,743 Retained profit 2024: € 303,743 ▲ 41% vs 2023 (€ 215,599) Favourable step	€ 332,601 Retained profit 2025: € 332,601 ▲ 10% vs 2024 (€ 303,743) Favourable step	▲ 10%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 1,600 Dividend 2023: € 1,600 Unchanged (€ 1,600) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 1,600) Unchanged	€ 70,500 Dividend 2025: € 70,500 Unchanged (€ 0) Unchanged
Balance sheet total	€ 235,746 Balance sheet total 2022: € 235,746 First fiscal year in the series	€ 285,407 Balance sheet total 2023: € 285,407 ▲ 21% vs 2022 (€ 235,746) Unchanged	€ 389,077 Balance sheet total 2024: € 389,077 ▲ 36% vs 2023 (€ 285,407) Unchanged	€ 413,317 Balance sheet total 2025: € 413,317 ▲ 6% vs 2024 (€ 389,077) Unchanged	▲ 6%

Key figures of DR. E. OBRIE - DR. H. VAN HOOREBEKE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. E. OBRIE - DR. H. VAN HOOREBEKE?

What happened at DR. E. OBRIE - DR. H. VAN HOOREBEKE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 99,357 (▲ 13% vs 2024). filed late Source: NBB ↗
Jul 5, 2000 New establishment in Kaprijke. KBO
Jul 5, 2000 Start of the company according to the CBE. KBO

In short

From € 41,591 profit in 2022 to € 99,357 profit in 2025.

Paid € 100,464 in corporate taxes since 2022.

Best year ever: 2025, with € 99,357 profit.

Paid out € 73,700 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. E. OBRIE - DR. H. VAN HOOREBEKE? We notify you, reason included.

Follow DR. E. OBRIE - DR. H. VAN HOOREBEKE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Eric Obrie Hilde Van Hoorebeke

DR. E. OBRIE - DR. H. VAN HOOREBEKE

Behind DR. E. OBRIE - DR. H. VAN HOOREBEKE are Eric Obrie and Hilde Van Hoorebeke.

See the full network in the app

Directors

According to the 2025 annual accounts

Eric Obrie

Director

Hilde Van Hoorebeke

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gravin Mad. d'Alcantaralaan 67

9971 Kaprijke

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Nucleaire Geneeskunde Az Alma

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0472.308.440
VAT number: BE 0472.308.440
Registered office: Gravin Mad. d'Alcantaralaan 67, 9971 Kaprijke
Names & denominations: DR. E. OBRIE - DR. H. VAN HOOREBEKE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 July 2000
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗